Search Orphan Drug Designations and Approvals
-
| Generic Name: | CD40/CD80/CD86 modified autologous dendritic cell therapy |
|---|---|
| Date Designated: | 12/20/2013 |
| Orphan Designation: | Treatment Type 1 diabetes mellitus patients with residual beta cell function |
| Orphan Designation Status: | Designated |
| FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
| Sponsor: |
DiaVacs, Inc. 410 Tower Drive Edgewater, New Jersey 07020 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-







